Literature DB >> 6370689

Hepatitis B virus antigens made in microbial cells immunise against viral infection.

K Murray, S A Bruce, A Hinnen, P Wingfield, P M van Erd, A de Reus, H Schellekens.   

Abstract

Chimpanzees have been vaccinated successfully against hepatitis B virus with preparations of the viral antigens made in microbial cells by genetic engineering methods.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6370689      PMCID： PMC557401          DOI： 10.1002/j.1460-2075.1984.tb01861.x

Source DB:  PubMed          Journal:  EMBO J        ISSN： 0261-4189            Impact factor:   11.598


  34 in total

1.  Hepatitis B e antigen and infectivity of hepatitis B virus.

Authors:  T Shikata; T Karasawa; K Abe; T Uzawa; H Suzuki; T Oda; M Imai; M Mayumi; Y Moritsugu
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

2.  e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants.

Authors:  K Okada; I Kamiyama; M Inomata; M Imai; Y Miyakawa
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

3.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

Review 4.  The genome of hepatitis B virus.

Authors:  W S Robinson
Journal:  Annu Rev Microbiol       Date:  1977       Impact factor: 15.500

5.  New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

Authors:  L O Magnius; J A Espmark
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

6.  Clottable protein in Limulus; its localization and kinetics of its coagulation by endotoxin.

Authors:  J Levin; F B Bang
Journal:  Thromb Diath Haemorrh       Date:  1968-03-31

7.  Correlations between the detection of e antigen or antibody and electron microscopic pattern of hepatitis B surface antigen (HBsAg) associated particles in the serum of HBsAg carriers.

Authors:  C Trepo; R G Bird; A J Zuckerman
Journal:  J Clin Pathol       Date:  1977-03       Impact factor: 3.411

8.  Identification of additional antigenic sites on Dane particles and the tubular forms of hepatitis B surface antigen.

Authors:  A R Neurath; C Trepo; M Chen; A M Prince
Journal:  J Gen Virol       Date:  1976-03       Impact factor: 3.891

9.  Letter: Infectivity of serum containing HBsAg and antibody to e antigen.

Authors:  K R Berquist; J E Maynard; B L Murphy
Journal:  Lancet       Date:  1976-05-08       Impact factor: 79.321

10.  DNA polymerase associated with human hepatitis B antigen.

Authors:  P M Kaplan; R L Greenman; J L Gerin; R H Purcell; W S Robinson
Journal:  J Virol       Date:  1973-11       Impact factor: 5.103
View more
  29 in total

1.  DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines.

Authors:  H L Davis; M J McCluskie; J L Gerin; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 2.  Recombinant avirulent salmonellae as oral vaccine carriers.

Authors:  F Schödel
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

3.  Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope.

Authors:  D R Milich; J L Hughes; A McLachlan; G B Thornton; A Moriarty
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

4.  Immunogenicity of peptide fusions to hepatitis B virus core antigen.

Authors:  S J Stahl; K Murray
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Cellular immunity to nucleocapsid and pre-S determinants in asymptomatic carriers of hepatitis B virus.

Authors:  S Vento; S H Chen; G Giuliani-Piccari; C J O'Brien; P R Dal Monte; A L Eddleston; C R Howard; R Williams
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

6.  Chimeric rabbit/human Fab antibodies against the hepatitis Be-antigen and their potential applications in assays, characterization, and therapy.

Authors:  Xiaolei Zhuang; Norman R Watts; Ira W Palmer; Joshua D Kaufman; Altaira D Dearborn; Joni L Trenbeath; Elif Eren; Alasdair C Steven; Christoph Rader; Paul T Wingfield
Journal:  J Biol Chem       Date:  2017-08-23       Impact factor: 5.157

7.  Easing the global burden of diarrhoeal disease: can synthetic biology help?

Authors:  Prerna Vohra; Garry W Blakely
Journal:  Syst Synth Biol       Date:  2013-07-20

8.  Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.

Authors:  Jinguo Wang; Shashi A Gujar; Lucyna Cova; Tomasz I Michalak
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination.

Authors:  F Schödel; S M Kelly; D L Peterson; D R Milich; R Curtiss
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  Chimeric hepatitis B virus core particles with parts or copies of the hepatitis C virus core protein.

Authors:  A Yoshikawa; T Tanaka; Y Hoshi; N Kato; K Tachibana; H Iizuka; A Machida; H Okamoto; M Yamasaki; Y Miyakawa
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.